Step Towards Creating a Vaccine for HIV
The scientific group headed by Professor Andrei Kozlov published the results of a study devoted to the search of solutions for creating the HIV vaccine. Credit: Peter the Great St. Petersburg Polytechnic University
The scientific group of Peter the Great St.Petersburg Polytechnic University headed by Professor Andrei Kozlov published the results of a study devoted to the search of solutions for creating the HIV vaccine.
During two years, with the support of the Russian Science Foundation's grant, researchers studied features of transmitted variants of HIV-1 virus. This type of HIV transmission is most typical for Russian Federation.
Within the framework of the project, scientists have studied blood samples of injecting drug users with acute or early stages of HIV infection. The transmission of only one viral variant was detected in 70% of cases. These data were obtained by the method of single genome analysis (SGA), which allows to analyze 20-30 single genomes. In addition, the scientific group used the next-generation sequencing approach (NGS), capable of analyzing up to 5000 genomes. Thus, scientists managed to establish that all viruses are the "descendants" of any one virus particle. This phenomenon is called the genetic bottleneck effect. The research results are described in the article "Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use" published in the journal AIDS Research and Human Retroviruses.
"Though this work is fundamental, we are working with the genes of the viruses, which can be used in design of vaccine against HIV. So to speak, it is necessary to create the vaccine not against all possible viruses, but against those which are transmitted and cause the infection. We will use these data in the further work on HIV vaccine development", notes Professor Kozlov
This article has been republished from materials provided by Peter the Great St.Petersburg Polytechnic University. Note: material may have been edited for length and content. For further information, please contact the cited source.
WHO welcomes the Government of Malawi’s launch of the world’s first malaria vaccine today in a landmark pilot programme. The country is the first of three in Africa in which the vaccine, known as RTS,S, will be made available to children up to 2 years of age; Ghana and Kenya will introduce the vaccine in the coming weeks.READ MORE